Trial intelligence / Profile preview

Efficacy and Acceptability of Two Lubricant Eye Drops

NCT00756678Phase 4Completed

Sponsor
Allergan
Start
Sep 2008
Primary completion
Aug 2009
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of carboxymethylcellulose sodium + glycerin in dry eye syndrome (DED) (2 arms), sponsored by Allergan. Primary endpoint: Mean Frequency of Eye Drop Use Over 1 Week. Started Sep 2008; status: completed.

02

Drugs

carboxymethylcellulose sodium + glycerin
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT00756678.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00756678.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call